Literature DB >> 18257166

Tiotropium and the treatment of chronic obstructive pulmonary disease.

Nick R Anthonisen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18257166      PMCID： PMC2677767          DOI： 10.1155/2007/907027

Source DB:  PubMed          Journal:  Can Respir J        ISSN： 1198-2241            Impact factor:   2.409


× No keyword cloud information.
  9 in total

1.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

2.  Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

Authors:  Dennis E Niewoehner; Kathryn Rice; Claudia Cote; Daniel Paulson; J Allen D Cooper; Larry Korducki; Cara Cassino; Steven Kesten
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

3.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Authors:  R Casaburi; D A Mahler; P W Jones; A Wanner; Pedro G San; R L ZuWallack; S S Menjoge; C W Serby; T Witek
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

4.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  Peter Calverley; Romain Pauwels; Jørgen Vestbo; Paul Jones; Neil Pride; Amund Gulsvik; Julie Anderson; Claire Maden
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

5.  Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Dean Fergusson; François Maltais; Jean Bourbeau; Roger Goldstein; Meyer Balter; Denis O'Donnell; Andrew McIvor; Sat Sharma; Graham Bishop; John Anthony; Robert Cowie; Stephen Field; Andrew Hirsch; Paul Hernandez; Robert Rivington; Jeremy Road; Victor Hoffstein; Richard Hodder; Darcy Marciniuk; David McCormack; George Fox; Gerard Cox; Henry B Prins; Gordon Ford; Dominique Bleskie; Steve Doucette; Irvin Mayers; Kenneth Chapman; Noe Zamel; Mark FitzGerald
Journal:  Ann Intern Med       Date:  2007-02-19       Impact factor: 25.391

6.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

7.  Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.

Authors:  P M Calverley; W Boonsawat; Z Cseke; N Zhong; S Peterson; H Olsson
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

8.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

9.  A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease.

Authors:  Charles K N Chan; François Maltais; Chris Sigouin; Jennifer M Haddon; Gordon T Ford
Journal:  Can Respir J       Date:  2007 Nov-Dec       Impact factor: 2.409
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.